Stock STIM NEURONETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Share ownership Neuronetics, Inc.

Equities

STIM

US64131A1051

Advanced Medical Equipment & Technology

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-17 pm EST 		5-day change 1st Jan Change
2.460 USD +7.89% Intraday chart for Neuronetics, Inc. +5.13% +52.80%
Jan. 13 Neuronetics, Inc. Announces Unaudited Revenue Results for Fourth Quarter and Full Year 2024 CI
Jan. 13 Neuronetics, Inc. Provides Earnings Guidance for the Full Year 2025 CI

Share class: Neuronetics, Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A155,652,47526,983,307 ( 48.49 %) 0 48.49 %

Major shareholders: Neuronetics, Inc.

NameEquities%Valuation
Madryn Asset Management LP
43.55 %
24,237,061 43.55 % 39 M $
Kent Lake PR LLC
3.734 %
2,077,848 3.734 % 3 M $
Sasha Cucuz
3.424 %
1,905,626 3.424 % 3 M $
Cannell Capital LLC
2.362 %
1,314,266 2.362 % 2 M $
Vanguard Global Advisers LLC
2.336 %
1,299,915 2.336 % 2 M $
Masters Capital Management LLC
2.156 %
1,200,000 2.156 % 2 M $
Balyasny Asset Management LP
2.056 %
1,144,232 2.056 % 2 M $
Keith Sullivan
1.329 %
739,687 1.329 % 1 M $
Renaissance Technologies LLC
1.045 %
581,800 1.045 % 936 698 $
FourWorld Capital Management LLC
0.9066 %
504,557 0.9066 % 812 337 $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░ ░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional61.35%
Individuals7.63%
Other0.80%
State Street Corp.0.18%
Unknown30.04%

Based on 1000 largest holdings

Geographical origin of shareholders

United States 58.42%
Individuals 7.63%
United Kingdom 0.18%

Based on 1000 largest holdings

Company Profile

Logo Neuronetics, Inc.
Neuronetics, Inc. is a commercial-stage medical technology company. The Company is focused on designing, developing and marketing products for patients who suffer from neurohealth disorders. Its commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation (TMS) to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The NeuroStar Advanced Therapy System is used to treat adult patients with major depressive disorder (MDD). The Company intends to continue to pursue development of its NeuroStar Advanced Therapy System for additional indications. The Company sells its NeuroStar Advanced Therapy System and recurring treatment sessions in the United States. Its primary focus is on selling to psychiatrists, with primary care physicians and pain management specialists.
Employees
201
Sector
Advanced Medical Equipment & Technology
Calendar
2025-03-10 - Q4 2024 Earnings Release (Projected)
More about the company
  1. Stock Market
  2. Equities
  3. STIM Stock
  4. Company Neuronetics, Inc.
  5. Share ownership